Company / Working Capital per Share
REGENXBIO Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.29
FY2025
5-year range
$3.29 / $10.36
FY2021-FY2025
Trend
-17.0%
vs FY2024
Sector context
#134 of 210
Health Care
What the data says
At $3.29, REGENXBIO Inc.'s working capital per share ranks #134 of 210 in the Health Care sector. Working Capital per Share has declined for 5 consecutive years, from $12.16 in FY2020 to $3.29 in FY2025.
Based on SEC 10-K filings.
3.29 in FY2025 with a 5-year CAGR of -23.0%.
Declined from $4.73 to $3.29 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -20.9%
- 5-Year CAGR
- -23.0%
- 10-Year CAGR
- -
Sector benchmark
#134 of 210 in Health CareTop 64% of 210This company $3.29 Sector average $118.60
▼
-97.2% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 17.0% year-over-year.
- Ranks #134 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.29 | -17.0% |
| FY2024 | $3.97 | -16.1% |
| FY2023 | $4.73 | -29.1% |
| FY2022 | $6.67 | -35.7% |
| FY2021 | $10.36 | -14.8% |
| FY2020 | $12.16 | +41.0% |
| FY2019 | $8.62 | -14.6% |
| FY2018 | $10.09 | +74.0% |
| FY2017 | $5.80 | +82.3% |
| FY2016 | $3.18 | -92.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026